4//SEC Filing
Corin Denis 4
Accession 0001405626-18-000005
CIK 0001596062other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 5:15 PM ET
Size
6.4 KB
Accession
0001405626-18-000005
Insider Transaction Report
Form 4
Q BioMed Inc.QBIO
CORIN DENIS
DirectorChief Executive Officer10% Owner
Transactions
- Sale
Common Stock
2018-06-29$3.40/sh−2,100$7,138→ 2,473,500 total - Sale
Common Stock
2018-06-28$3.39/sh−5,300$17,961→ 2,475,600 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2018 for the sale of up to 139,871 shares of common stock. Such sales were outside the Reporting Person's investment decision.
Documents
Issuer
Q BioMed Inc.
CIK 0001596062
Entity typeother
Related Parties
1- filerCIK 0001405626
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 5:15 PM ET
- Size
- 6.4 KB